All News

Top news of the day from across the health care industry.

The combination treatment (Duaklir, Circassia) is designed to be administered twice-daily via AstraZeneca’s breath-actuated inhaler (Pressair).

The combination therapy was approved for twice-daily administration via the breath-actuated Pressair inhaler in patients with COPD.

Avaclyr 3%, a herpes simplex virus nucleoside analog DNA polymerase inhibitor.

In addition to concerns about contamination, some products made by these companies that are labeled as homeopathic do not deliver any benefit, yet may potentially be harmful, according to the FDA.

Gilteritinib (Xospata) was superior to standard chemotherapy in improving overall survival in patients with acute myeloid leukemia.

Why did this patient's warfarin dose triple?

Top news of the day from across the health care industry.

Benzodiazepines are involved in over 30% of opioid overdoses. It is important to learn about this combination and how to counsel patients.

This article will describe the unusual discovery of 5 commonly prescribed medications, many of which were through serendipitous events.

Cladribine (Mavenclad, EMD Serono) is the first oral multiple sclerosis drug to demonstrate 2 years of proven efficacy with a maximum of 20 days of treatment.

Cladribine (Mavenclad, EMD Serono) is the first oral multiple sclerosis drug to demonstrate 2 years of proven efficacy with a maximum of 20 days of treatment.

Study data suggest the drug helps reduce the risk of major adverse cardiovascular event in certain patients.

The goals are to assess the candidate’s safety and to determine if the vaccination induces the human immune system to produce proteins called neutralizing antibodies.